Sun Pharmaceutical

Results: 79



#Item
51I  111TH CONGRESS 2D SESSION  H. R. 4520

I 111TH CONGRESS 2D SESSION H. R. 4520

Add to Reading List

Source URL: www.fda.gov

Language: English
52May 17,2006 The Honorable Nathan Deal Chairman Subcommittee on Health Committee on Energy and Commerce 2125 Rayburn House Office Building

May 17,2006 The Honorable Nathan Deal Chairman Subcommittee on Health Committee on Energy and Commerce 2125 Rayburn House Office Building

Add to Reading List

Source URL: maloney.house.gov

Language: English - Date: 2009-01-13 15:52:03
53Chapter 1  Pre-formulation Design and Considerations Howard Epstein, PhD EMD Chemicals

Chapter 1 Pre-formulation Design and Considerations Howard Epstein, PhD EMD Chemicals

Add to Reading List

Source URL: www.alluredbooks.com

Language: English - Date: 2013-12-09 16:45:52
54DISCLOSURE QUESTIONAIRE Certified B Corporations must complete a Disclosure Questionnaire to identify potentially sensitive issues related to the company (e.g. historical fines, sanctions, litigation, or sensitive indust

DISCLOSURE QUESTIONAIRE Certified B Corporations must complete a Disclosure Questionnaire to identify potentially sensitive issues related to the company (e.g. historical fines, sanctions, litigation, or sensitive indust

Add to Reading List

Source URL: www.bcorporation.net

Language: English - Date: 2014-05-27 20:30:25
55Health Tips from your friends at United Way & familywize Enjoy the warmth and sun of summer, but consider these warnings. Not only can some medicines be harmed by heat or sunlight, but you can be harmed by the sun when y

Health Tips from your friends at United Way & familywize Enjoy the warmth and sun of summer, but consider these warnings. Not only can some medicines be harmed by heat or sunlight, but you can be harmed by the sun when y

Add to Reading List

Source URL: www.gmunitedway.org

Language: English - Date: 2014-07-24 13:54:48
56June[removed]CRISIL Insight Indian pharma well-placed to weather spurt in FDA actions

June[removed]CRISIL Insight Indian pharma well-placed to weather spurt in FDA actions

Add to Reading List

Source URL: www.crisil.com

Language: English - Date: 2014-07-03 07:11:55
57Clinical Review  Joseph M. Porres MD, PhD NDA 22009, N-000 Helioblock-SX

Clinical Review Joseph M. Porres MD, PhD NDA 22009, N-000 Helioblock-SX

Add to Reading List

Source URL: www.fda.gov

Language: English
58DEPARTMENT OF HEALTH & HUMAN SERVICES  Public Health Service Division of Nonprescription Products (DNCE) Office of Nonprescription Products (ONP)

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Division of Nonprescription Products (DNCE) Office of Nonprescription Products (ONP)

Add to Reading List

Source URL: www.fda.gov

Language: English
59Microsoft Word - JEP-FDA-Philipson-and-Sun-Final_nber.doc

Microsoft Word - JEP-FDA-Philipson-and-Sun-Final_nber.doc

Add to Reading List

Source URL: www.nber.org

Language: English - Date: 2007-10-26 10:22:20
60Case 1:14-cv[removed]JBS-KMW Document 1 Filed[removed]Page 1 of 11 PageID: 1  UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff,

Case 1:14-cv[removed]JBS-KMW Document 1 Filed[removed]Page 1 of 11 PageID: 1 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY OTSUKA PHARMACEUTICAL CO., LTD., Plaintiff,

Add to Reading List

Source URL: patentdocs.typepad.com

Language: English - Date: 2014-07-30 00:06:29